Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Fabiana Higashi"'
Autor:
Maricy Almeida Viol Ferreira Lopes, Fabiana Higashi, Edvan de Queiroz Crusoe, Ana Lucia Miguel Peres, Priscilla Cury, Vania Tietsche de Moraes Hungria
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss 2, Pp 259-265 (2023)
Introduction: Multiple myeloma is characterized by proliferation of clonal plasma cells. The identification of prognostics factors to identify patient's risk is important. Among the studied factors, it was identified of relevant importance the lactic
Externí odkaz:
https://doaj.org/article/cfef73e5e75d4719aa1a19709599ec9f
Autor:
Priscilla Cury de Camargo Cury, Fabiana Higashi, Flávia Fernandes Silva Zacchi, Renata Bacic Palhares, Adriana Alvares Quero, Ana Luiza Miranda Silva Dias, Edvan de Queiroz Crusoé, Vania Tietsche de Moraes Hungria
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 2, Pp 159-163 (2020)
Background: Bone marrow angiogenesis is increased in multiple myeloma (MM) patients, prompting the rationale for using antiangiogenic drugs in the treatment of these patients. Objective: To assess angiogenesis in patients with MM at diagnosis and fol
Externí odkaz:
https://doaj.org/article/32f1b996d4044af194cc9e5d9584c08b
Autor:
Edvan De Queiroz Crusoe, Fabiana Higashi, Gracia Martinez, Rosane Bittencourt, Jorge Vaz Pinto Neto, Lais Sousa, Rodrigo Santucci, Roberto José Pessoa Magalhães, Gilberto Colli, Renata Ferreira Marques Nunes, Glaciano Ribeiro, Jandir Nicacio, Karla Richter Zanella, Jose Mauro Kutner, Andre Magalhaes, Danielle Leao, Abrahão Elias Hallack Neto, Walter Braga, Emanuella G Souza, Antonio Julio A.M. Guimaraes, Giovanna Steffenello Durigon, Dani Laks, Angelo Maiolino, Vania Tietsche de Moraes Hungria
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 2, Pp 118-124 (2020)
Background: The treatment of multiple myeloma (MM) has evolved significantly in the past decade, and new drug combinations have improved the response rates and prolonged survival. Studies comparing different induction chemotherapy regimens have shown
Externí odkaz:
https://doaj.org/article/dd8ebf2a8a304f048bea1d07e647aa46
Autor:
Ana Luiza Miranda Silva Dias, Fabiana Higashi, Ana Lúcia M. Peres, Pricilla Cury, Edvan de Queiroz Crusoé, Vânia Tietsche de Moraes Hungria
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 40, Iss 1, Pp 30-36 (2018)
Introduction: The estimated involvement of the central nervous system in patients with multiple myeloma is rare at about 1%. The infiltration can be identified at the time multiple myeloma is diagnosed or during its progression. However, it is more c
Externí odkaz:
https://doaj.org/article/05b7ce73899b4191b46a67d49e322b91
Autor:
Thais Rodrigues da Cunha Fischer, Fabiana Higashi, Edvan de Queiroz Crusoe, Vania Tietsche de Moraes Hungria
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 38, Iss 2, Pp 166-169 (2016)
Externí odkaz:
https://doaj.org/article/aeee676a13934919a9f9d60c2f51b4e2
Autor:
Edvan de Queiroz Crusoe, Fabiana Higashi, Maria Paula Nalesso Camargo Padilha, Eliana Cristina Martins Miranda, Adriana Alvares Quero, Manuella de Souza Sampaio Almeida, Ana Lucia M. Peres, Priscilla Cury, Carlos Chiattone, Jose Carlos Barros, Vania Tietsche de Moraes Hungria
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 36, Iss 1, Pp 19-24 (2014)
Background: Induction therapy followed by high-dose chemotherapy and autologous transplantation is the standard treatment for suitable patients with multiple myeloma. Objective: The aim of this study was to assess whether induction therapy with thali
Externí odkaz:
https://doaj.org/article/00490626cf084f76809b5e5b1ae827b8
Autor:
Edvan de Queiroz Crusoe, Fabiana Higashi, Gracia Aparecida Martinez, José Carlos Barros, Marcelo Bellesso, Marina Rossato, Ana Cinira F. Marret, Carlos Sérgio Chiattone, Vania Tietsch de Moraes Hungria
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 38, Iss 4, Pp 302-309
ABSTRACT Background: Cyclophosphamide plus thalidomide as induction for multiple myeloma patients eligible for autologous stem cell transplantation may be a limiting factor for cell mobilization. The minimum acceptable mobilized peripheral blood stem
Externí odkaz:
https://doaj.org/article/e1b9cfae18ed4946b29fe8e6a1b26587
Autor:
Maricy Almeida Viol Ferreira Lopes, Fabiana Higashi, Edvan de Queiroz Crusoe, Ana Lucia Miguel Peres, Priscilla Cury, Vania Tietsche de Moraes Hungria
Publikováno v:
Hematology, Transfusion and Cell Therapy, Volume: 45, Issue: 2, Pages: 259-265, Published: 07 JUL 2023
Introduction Multiple myeloma is characterized by proliferation of clonal plasma cells. The identification of prognostics factors to identify patient's risk is important. Among the studied factors, it was identified of relevant importance the lactic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d20fe4ecad1c9f791fe9da5e30f26044
https://pubmed.ncbi.nlm.nih.gov/36114115
https://pubmed.ncbi.nlm.nih.gov/36114115
Autor:
Gilberto Colli, Fabiana Higashi, Antonio Julio A.M. Guimaraes, Roberto José Pessoa Magalhães, Danielle Leao, Gracia Martinez, Vania Hungria, Andre Magalhaes, Jandir Nicacio, Jorge Vaz Pinto Neto, Rosane Bittencourt, Glaciano Ribeiro, Renata Ferreira Marques Nunes, Angelo Maiolino, Walter Moises Tobias Braga, Lais Sousa, Giovanna Steffenello Durigon, Dani Laks, Abrahão Elias Hallack Neto, Jose Mauro Kutner, Emanuella G Souza, Rodrigo Santucci, Edvan de Queiroz Crusoe, Karla Richter Zanella
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 2, Pp 118-124 (2020)
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy
Background The treatment of multiple myeloma (MM) has evolved significantly in the past decade, and new drug combinations have improved the response rates and prolonged survival. Studies comparing different induction chemotherapy regimens have shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5c7bb8e25622d621b2d8259cbd4e34
http://www.sciencedirect.com/science/article/pii/S253113791930118X
http://www.sciencedirect.com/science/article/pii/S253113791930118X
Autor:
Edvan Crusoe, Glaciano Ribeiro, Karla Zanella, Leila Perobelli, Renato Centrone, Emanuella Souza, Rosane Bittencourt, Roberto Magalhaes, Fabio Moreno, Joao Saraiva, Lucas Cantadori, Danielle Ovigli, Fabiana Higashi, Cleder araujo, Walter Braga, Breno Gusmao, Abrahao Hallack, Caroline Sola, Gracia Matinez, Nelson Castro, Joao Souto, Luiza Soares, Ederson Mattos, Angelo Maiolino, Vania Hungria
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S106-S107
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8e52ac3a88fd8a284730354c82fcdfe
https://doi.org/10.1016/s2152-2650(22)00460-8
https://doi.org/10.1016/s2152-2650(22)00460-8